I have 40 years of experience, and specialize in the field of pharmaceuticals with specific knowledge in the areas of business development, mergers and acquisition, biotechnology startup companies as a chief executive officer of those companies and Wall Street initial public offering financings and corporate governance. I have published on such topics as new product development, starting and developing new pharmacy/biotechnology companies and acquisition of new products and companies.